Federal Judge Rules that Medtronic Shareholder Lawsuit, Brought by Three Key Investor Groups May Pro
Investors allege that Medtronic misled them about Infuse’s safety profile and potential commercial possibilities. Port Washington, New York (PRWEB) October 20, 2014 A federal judge in Minneapolis, Minnesota just ruled that a shareholder lawsuit brought over Medtronic’s Infuse bone growth protein may proceed. The lawsuit alleges that Medtronic and its management, which includes its former CEO, William Hawkins, misled investors concerning the safety and potential commercial viability of Infuse. The case is West Virginia Pipe Trades Health & Welfare Fund v. Medtronic, Inc. et al., in the
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Related Documents in PR Web
- Electrical Safety Foundation International to Kick off Anti-counterfeiting Webinar Series on Wednesd
- Celestix Enables Seamless Active Directory Integration with Office 365 for a Single Sign-On Experien
- Brassica Protection Products Expands Exclusive License Agreement with Johns Hopkins University for B
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4